livemint.com
84%
315
Drugmakers slash prices of covid-19 drug remdesivir
₹899-3,490 per vial from the earlier price of ₹2,800-5,400 per vial NEW DELHI : Seven pharmaceutical companies which manufacture remdesivir in India have slashed the prices of the drug, given to patients with severe covid-19 in hospitals, by at least a fourth after the government urged them to do it.The seven companies—Cadila Healthcare, Syngene International, Dr Reddy's Laboratories, Cipla, Viatris (which was earlier Mylan), Jubilant Generics and Hetero Healthcare—are contract manufacturers of the intravenous drug through a voluntary licensing agreement with its US-based innovator Gilead Sciences Inc.The companies will now be selling the drug in the range of ₹899-3,490 per vial from the earlier price of 2,800-5,400 per vial.Cadila